In a highly challenging case, a 55-year-old woman suffering from a complex renal tumor located dangerously close to the ...
As part of the transaction, Chugai will gain exclusive rights to develop and commercialize sparsentan in Japan, South Korea and Taiwan. On September 26, 2025, CSL Vifor and Travere announced support ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback